cancer treatment

Researchers report observing how an aggressive brain cancer physically remodels brain tissue as it grows, offering a live view of tumor progression. The findings shed light on how deadly brain tumors invade and distort surrounding structures, which could inform future treatment approaches. The work is drawing attention for its striking visualization of the disease's effects on the brain.

Coverage is circulating of the second part of a highlights roundup from the World Cancer Congress 2026, summarising key presentations and developments shared at the global oncology gathering. The roundup is aimed at cancer professionals and researchers following the congress remotely, distilling sessions into digestible takeaways. Interest centres on what new research, treatment approaches and policy discussions were featured at this year's event.

A new study shows how loss of parts of the Y chromosome, a common age-related change in men's cells, can promote cancer growth. Researchers report the missing pieces help tumours evade immune defences, offering a possible explanation for why some cancers in men are more aggressive and opening paths to new treatments.

A new report outlines how biological research is changing the way breast cancer is diagnosed and treated. Understanding tumour biology is increasingly guiding treatment choices, moving care away from one-size-fits-all approaches toward therapies matched to the specific characteristics of each patient's cancer. The piece has drawn attention from clinicians and patient advocates following shifts in treatment standards.

NPR has published the story of a professor who was diagnosed with lung cancer and underwent cutting-edge treatment, reportedly involving mRNA-based approaches and questions of affordability. The piece follows his shift from expert observer to patient navigating new therapies. It is drawing attention as a personal account of where lung cancer treatment stands and who can access it.

Researchers have highlighted three previously overlooked RNA molecules as potential new markers for colorectal cancer. The findings suggest these molecules could help detect the disease earlier and guide treatment choices, offering a possible addition to existing screening and diagnostic tools. Colorectal cancer remains one of the most common cancers worldwide, so any lead on earlier detection is drawing scientific and media attention.

A New York Times opinion piece asks why clinical trials for cancer drugs take so long, examining delays in the process of testing new treatments on patients. The article prompts discussion about whether trial design, regulatory requirements, or patient recruitment are the main bottlenecks in getting promising cancer therapies to people faster.

Dr. Ilyas Sahin has drawn attention to a new scientific study on colorectal cancer liver metastasis, one of the most common and difficult sites of colorectal cancer spread. The findings are being shared among oncology watchers interested in how the disease progresses and what new treatment approaches might follow.

UT Health San Antonio is working to find a cure for liver cancer, a disease affecting communities across South Texas at elevated rates. The health institution's research efforts were highlighted in local coverage, drawing attention to the region's particular vulnerability and the push for better treatments.